Original Source(s)
Related Content
FDA, CMS target gene therapy barriers
FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases.
by Mouj Hijazi
October 29, 2026
-
4 min
FDA approves first at-home therapy for thyroid eye disease
The first at-home subcutaneous treatment for thyroid eye disease met its primary end point in 1 of 2 phase 3 trials.
by Mouj Hijazi
October 16, 2026
-
2 min
FDA approves dostarlimab for advanced rectal cancer
The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.
by Mouj Hijazi
October 19, 2026
-
3 min
